In summary, we identified that the feedback loop of STAT1-IFITM3 maintains Treg function and stability in the tumor microenvironment, which provides innovative insights and targets to achieve anti-tumor immunity in clinical patients. This evidence concerns the gene IFITM3 and neoplasm.